Differential effect of recombinant tissue plasminogen activator-induced thrombolysis in the central nervous system and systemic arteries

B. B. Chehrazi, J Anthony Seibert, L. Hein, J. Brock, P. Kissel

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Recombinant tissue plasminogen activator (rTPA) has been more effective in inducing thrombolysis in laboratory studies of intracranial thrombosis than clinical studies of systemic or coronary thrombosis would indicate. To evaluate this discrepancy, 21 rabbits were subjected to embolic occlusion of the right internal carotid artery (ICA) by retrograde injection of a tin-tagged, 2-hour-old autologous clot through the external carotid artery with angiographic monitoring in the same manner as in a previously reported model. The emboli lodged intracranially at the bifurcation of the ICA in 10 animals and in the cervical ICA in 11 animals. Digital subtraction angiography confirmed total occlusion of the ICA in all animals. Treatment started one-half hour after embolization and consisted of a bolus of 0.5 mg/kg of rTPA followed by an infusion of 1 mg/kg/h for 2 hours. All of the animals with intracranial emboli and 6 of the animals with cervical emboli were treated intravenously. The remaining 5 animals with cervical emboli were treated by intracarotid infusion of the same dose of rTPA. In the intravenously treated group, serial digital subtraction angiography documented thrombolysis in 9 of the 10 animals with intracranial emboli and only 1 of the 6 with cervical emboli. Thrombolysis occurred in 4 of the 5 rabbits with cervical emboli treated with intracarotid rTPA. Intravenous rTPA therapy produced a significantly (P < 0.01) higher rate of thrombolysis in intracranial as compared to cervical thromboembolic occlusion of intracranial arteries than of systemic arteries, and that intra-arterial rTPA therapy may be indicated for treatment of acute systemic arterial occlusions. Anatomical and physiological differences between the cervical and the intracranial segments of the carotid artery may affect the response to rTPA-induced thrombolysis.

Original languageEnglish (US)
Pages (from-to)364-369
Number of pages6
JournalNeurosurgery
Volume28
Issue number3
StatePublished - 1991

Fingerprint

Tissue Plasminogen Activator
Embolism
Central Nervous System
Arteries
Internal Carotid Artery
Digital Subtraction Angiography
Rabbits
Coronary Thrombosis
External Carotid Artery
Intracranial Thrombosis
Tin
Therapeutics
Carotid Arteries
Injections

Keywords

  • Cerebral embolism
  • Cerebral infarction
  • Digital angiography
  • Plasminogen activator
  • Thrombolysis

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Differential effect of recombinant tissue plasminogen activator-induced thrombolysis in the central nervous system and systemic arteries. / Chehrazi, B. B.; Seibert, J Anthony; Hein, L.; Brock, J.; Kissel, P.

In: Neurosurgery, Vol. 28, No. 3, 1991, p. 364-369.

Research output: Contribution to journalArticle

@article{265bc79e7b774cdf974ba432e185549c,
title = "Differential effect of recombinant tissue plasminogen activator-induced thrombolysis in the central nervous system and systemic arteries",
abstract = "Recombinant tissue plasminogen activator (rTPA) has been more effective in inducing thrombolysis in laboratory studies of intracranial thrombosis than clinical studies of systemic or coronary thrombosis would indicate. To evaluate this discrepancy, 21 rabbits were subjected to embolic occlusion of the right internal carotid artery (ICA) by retrograde injection of a tin-tagged, 2-hour-old autologous clot through the external carotid artery with angiographic monitoring in the same manner as in a previously reported model. The emboli lodged intracranially at the bifurcation of the ICA in 10 animals and in the cervical ICA in 11 animals. Digital subtraction angiography confirmed total occlusion of the ICA in all animals. Treatment started one-half hour after embolization and consisted of a bolus of 0.5 mg/kg of rTPA followed by an infusion of 1 mg/kg/h for 2 hours. All of the animals with intracranial emboli and 6 of the animals with cervical emboli were treated intravenously. The remaining 5 animals with cervical emboli were treated by intracarotid infusion of the same dose of rTPA. In the intravenously treated group, serial digital subtraction angiography documented thrombolysis in 9 of the 10 animals with intracranial emboli and only 1 of the 6 with cervical emboli. Thrombolysis occurred in 4 of the 5 rabbits with cervical emboli treated with intracarotid rTPA. Intravenous rTPA therapy produced a significantly (P < 0.01) higher rate of thrombolysis in intracranial as compared to cervical thromboembolic occlusion of intracranial arteries than of systemic arteries, and that intra-arterial rTPA therapy may be indicated for treatment of acute systemic arterial occlusions. Anatomical and physiological differences between the cervical and the intracranial segments of the carotid artery may affect the response to rTPA-induced thrombolysis.",
keywords = "Cerebral embolism, Cerebral infarction, Digital angiography, Plasminogen activator, Thrombolysis",
author = "Chehrazi, {B. B.} and Seibert, {J Anthony} and L. Hein and J. Brock and P. Kissel",
year = "1991",
language = "English (US)",
volume = "28",
pages = "364--369",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Differential effect of recombinant tissue plasminogen activator-induced thrombolysis in the central nervous system and systemic arteries

AU - Chehrazi, B. B.

AU - Seibert, J Anthony

AU - Hein, L.

AU - Brock, J.

AU - Kissel, P.

PY - 1991

Y1 - 1991

N2 - Recombinant tissue plasminogen activator (rTPA) has been more effective in inducing thrombolysis in laboratory studies of intracranial thrombosis than clinical studies of systemic or coronary thrombosis would indicate. To evaluate this discrepancy, 21 rabbits were subjected to embolic occlusion of the right internal carotid artery (ICA) by retrograde injection of a tin-tagged, 2-hour-old autologous clot through the external carotid artery with angiographic monitoring in the same manner as in a previously reported model. The emboli lodged intracranially at the bifurcation of the ICA in 10 animals and in the cervical ICA in 11 animals. Digital subtraction angiography confirmed total occlusion of the ICA in all animals. Treatment started one-half hour after embolization and consisted of a bolus of 0.5 mg/kg of rTPA followed by an infusion of 1 mg/kg/h for 2 hours. All of the animals with intracranial emboli and 6 of the animals with cervical emboli were treated intravenously. The remaining 5 animals with cervical emboli were treated by intracarotid infusion of the same dose of rTPA. In the intravenously treated group, serial digital subtraction angiography documented thrombolysis in 9 of the 10 animals with intracranial emboli and only 1 of the 6 with cervical emboli. Thrombolysis occurred in 4 of the 5 rabbits with cervical emboli treated with intracarotid rTPA. Intravenous rTPA therapy produced a significantly (P < 0.01) higher rate of thrombolysis in intracranial as compared to cervical thromboembolic occlusion of intracranial arteries than of systemic arteries, and that intra-arterial rTPA therapy may be indicated for treatment of acute systemic arterial occlusions. Anatomical and physiological differences between the cervical and the intracranial segments of the carotid artery may affect the response to rTPA-induced thrombolysis.

AB - Recombinant tissue plasminogen activator (rTPA) has been more effective in inducing thrombolysis in laboratory studies of intracranial thrombosis than clinical studies of systemic or coronary thrombosis would indicate. To evaluate this discrepancy, 21 rabbits were subjected to embolic occlusion of the right internal carotid artery (ICA) by retrograde injection of a tin-tagged, 2-hour-old autologous clot through the external carotid artery with angiographic monitoring in the same manner as in a previously reported model. The emboli lodged intracranially at the bifurcation of the ICA in 10 animals and in the cervical ICA in 11 animals. Digital subtraction angiography confirmed total occlusion of the ICA in all animals. Treatment started one-half hour after embolization and consisted of a bolus of 0.5 mg/kg of rTPA followed by an infusion of 1 mg/kg/h for 2 hours. All of the animals with intracranial emboli and 6 of the animals with cervical emboli were treated intravenously. The remaining 5 animals with cervical emboli were treated by intracarotid infusion of the same dose of rTPA. In the intravenously treated group, serial digital subtraction angiography documented thrombolysis in 9 of the 10 animals with intracranial emboli and only 1 of the 6 with cervical emboli. Thrombolysis occurred in 4 of the 5 rabbits with cervical emboli treated with intracarotid rTPA. Intravenous rTPA therapy produced a significantly (P < 0.01) higher rate of thrombolysis in intracranial as compared to cervical thromboembolic occlusion of intracranial arteries than of systemic arteries, and that intra-arterial rTPA therapy may be indicated for treatment of acute systemic arterial occlusions. Anatomical and physiological differences between the cervical and the intracranial segments of the carotid artery may affect the response to rTPA-induced thrombolysis.

KW - Cerebral embolism

KW - Cerebral infarction

KW - Digital angiography

KW - Plasminogen activator

KW - Thrombolysis

UR - http://www.scopus.com/inward/record.url?scp=0026096939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026096939&partnerID=8YFLogxK

M3 - Article

C2 - 1901394

AN - SCOPUS:0026096939

VL - 28

SP - 364

EP - 369

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 3

ER -